Funding Agreements in the Pharmaceuticals Industry

62 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Grant Agreement between [Foundation] and Cingulate Therapeutics, LLC for CTx-2103 Development
Funding Agreements
Cingulate Inc.
Pharmaceuticals
2025
Second Amendment to Funding Agreement among Dermavant Sciences GmbH, Dermavant Sciences Ltd., and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
NIH Notice of Award to Cognition Therapeutics, Inc. for Alzheimer’s Disease Research (Award No. R01AG058660)
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
National Institutes of Health Grant Award to Cognition Therapeutics, Inc. for Dementia Research (Award No. R01AG071643)
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
Notice of Award for NIH Grant to Cognition Therapeutics, Inc. for Alzheimer's Research
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
National Institutes of Health (NIH) Notice of Award to Cognition Therapeutics, Inc. for Alzheimer’s Disease Clinical Trial
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Alzheimer’s Disease Research Project – Cognition Therapeutics, Inc. and National Institute on Aging
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Phase 1 Safety Trial of CT1812 – Cognition Therapeutics, Inc. and National Institute on Aging
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Alzheimer's Disease Research – Cognition Therapeutics, Inc. and National Institute on Aging
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Phase II Alzheimer's Study between National Institute on Aging and Cognition Therapeutics, Inc.
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Alzheimer’s Disease Research Project – Cognition Therapeutics, Inc.
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice to Cognition Therapeutics, Inc. for Alzheimer's Disease Research (R01AG057553)
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
NIH Grant Award Notice for Phase 1b CT1812 Alzheimer’s Safety Trial – Cognition Therapeutics, Inc. and National Institute on Aging
Funding Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
2021
First Amendment to Funding Agreement between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P. Funding Agreement (July 10, 2018)
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Bristol-Myers Squibb $33.5 Billion Senior Unsecured 364-Day Bridge Facility Commitment Letter with Morgan Stanley Senior Funding, Inc. and MUFG Bank, Ltd.
Funding Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2019
Research Funding Commitment Letter between Teva Pharmaceutical Industries Ltd. and Dr. Michael Hayden
Funding Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
2018
Funding Agreement Between Nuleaf, Inc. and Medifarm III, LLC for NuLeaf Reno Production, LLC
Funding Agreements
Terra Tech Corp.
Pharmaceuticals
NV
2017
Funding Agreement Between Nuleaf, Inc. and Medifarm III, LLC for Capital Contribution to Nuleaf Sparks Cultivation, LLC
Funding Agreements
Terra Tech Corp.
Pharmaceuticals
NV
2017
Definitive Funding Agreement between RxMM Health Limited and Players Network Inc.
Funding Agreements
PLAYERS NETWORK
Pharmaceuticals
NV
2016
Amended and Restated Commitment Letter for Senior Secured Credit Facilities – Lannett Company, Inc. and Lending Consortium
Funding Agreements
Lannett Company, Inc.
Pharmaceuticals
NY
2015
Commitment Letter for Senior Secured Credit Facilities – Lannett Company, Inc., Morgan Stanley Senior Funding, Inc., and Royal Bank of Canada
Funding Agreements
Lannett Company, Inc.
Pharmaceuticals
NY
2015
NIH Grant Award Notice to AllTranz, Inc. for Transdermal Cannabinoid Prodrug Research
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
2015
Kentucky Science and Technology Corporation Grant Agreement with AllTranz, Inc. for SBIR-STTR Matching Funds (KSTC-184-512-07-029)
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
KY
2015
Kentucky Science and Technology Corporation Grant Agreement with AllTranz, Inc. for SBIR-STTR Matching Funds
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
KY
2015
Kentucky Science and Technology Corporation Grant Agreement with AllTranz, Inc. for SBIR-STTR Matching Funds (2012-2013)
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
KY
2015
NIH Grant Award Notice to AllTranz, Inc. for Transdermal Cannabinoid Prodrug Research
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
2015
NIH Grant Award Notice for Transdermal Cannabidiol Prodrug Delivery Project (AllTranz Inc. and NIH/NIDA)
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
2015
NIH Grant Award Notice to AllTranz, Inc. for Transdermal Cannabinoid Prodrug Research
Funding Agreements
Zynerba Pharmaceuticals, Inc.
Pharmaceuticals
2015
Development and Funding Agreement between Proteo Biotech AG and Biotech Development Corp for Tiprelestat (Elafin)
Funding Agreements
PROTEO INC
Pharmaceuticals
NV
2014
NSF SBIR Phase I Grant Award Agreement between National Science Foundation and Angion Biomedica Corp.
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Aldosterone Synthase Inhibitor Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corp for Liver Fibrosis Therapeutic Project
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH SBIR Grant Award Notice to Angion Biomedica Corp. for Antifibrotic Therapy Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corp. for Anti-Fibrotic Therapy Research (SBIR Program)
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice for Angion Biomedica Corp. (SBIR Program, Project R43HL114298)
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Alcoholic Liver Disease Research
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Clinical Study on DGF Using Paired Kidneys
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for Renal Transplantation Clinical Study
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014
NIH Grant Award Notice to Angion Biomedica Corporation for LPA1 Antagonist Research (Grant No. 1R43AA021054-01A1)
Funding Agreements
Angion Biomedica Corp.
Pharmaceuticals
2014